Obamacare Creates 'Upheaval' At Free Clinics
While a few free health clinics have shut their doors in Arkansas and Washington, most expansion-state non-profit free clinics are reassessing their business strategies.
The PSA Debate Continues
The Lancet study, conducted in Europe, found a survival benefit with early diagnosis, but does not agree that the benefit outweighs some of the associated risks of the test.
Mutation in a BRCA2-Related Gene: Increased Risk of Breast Cancer
The study, published in NEJM, proposes enhanced surveillance in women with PALB2 mutations, similar to women harboring BRCA2 mutations.
How Employer-Based Health Insurance Actually Is Cheaper Than Government-Sponsored Insurance
Comparing the cost of employer-sponsored insurance to the cost of either Medicare or Medicaid is a completely stacked comparison even if we fully adjust for every iota of age and health status differences between these three populations and use an apples-to-apples comparison of plans having the identical benefits and actuarial value.
Use of Experimental Ebola Drug Raises Red Flags Among Medical Experts
What looks like a simple case of humanitarian goodwill could lead to some unintended and very negative consequences, experts said Tuesday.
Feds Stop Public Disclosure of Many Serious Hospital Errors
The federal government this month quietly stopped publicly reporting when hospitals leave foreign objects in patients' bodies or make a host of other life-threatening mistakes.
Cerner Spending $1.3 Billion for Siemens Health Tech Unit
Health technology and electronic health-record powerhouse Cerner Corp. is spending $1.3 billion to purchase Siemens Health Services, Siemens' health information technology business, Cerner announced Tuesday.
Senators Enquire on Policy for Biosimilars
Within a week of Sandoz applying for approval of it's biosimlar to Amgen's Neupogen, U.S. senators want the FDA to lay down guidelines on naming these drugs.
Experimental Drug Likely Saved Ebola Patients
On July 30, the Defense Threat Reduction Agency, an arm of the military responsible for any chemical, biological, radiological, nuclear and high-yield explosive threats, allotted additional funding to MAPP Biopharmaceutical due to "promising results."
Insurance Giants Creating Massive Database of Patient Records
Two of California's largest health insurers are partnering to create a massive database of patient medical records.
CMS Issues Final Rules for Inpatient, Hospice Payments
The CMS has finalized a rule (PDF) that decreases inpatient prospective payment system payments by $756 million overall. Meanwhile, long-term-care hospitals will see payments increase by 1.1%, or approximately $62 million in fiscal 2015, which starts Oct. 1.
FDA Accepts sNDA for Incyte's Jakafi
The results of ruxolitinib's RESPONSE trial were recently presented at ASCO's annual meeting.
AbbVie's Investigational Compound Receives Orphan Drug Designation by Both the FDA and EMA
ABT-414 is being developed to treat glioblastoma multiforme.
Hospital, Insurer Earnings Show Mixed Messages About Health Spending
Analysts who fear health spending is accelerating got plenty of evidence in Wall Street's second-quarter results to support their thesis. But so did folks who hope spending is still under control.
Justice Dept. Seeks Appeal in Health Overhaul Case
The Justice Department asked a full federal appeals court Friday to take up a case that has endangered subsidies helping millions of low- and middle-income people to afford their healthcare premiums under Obamacare.
Amgen's ASPIRE Trial Meets Primary Endpoint in Phase 3 for MM
The study evaluated carfilzomib in combination with Celgene's lenalidomide and dexamethasone.
Express Scripts Makes Value-Based Decisions for its Formulary
The pharmacy benefit manager has decided to choose formulations that provide equivalent benefit at lower cost.
HSF-1 Can Transform Stromal Cells to Promote Malignant Progression
The study, published in the journal Cell, was conducted at the Whitehead Institute of Biomedical Research.
Jardiance, a SGLT2 Inhibitor by Lilly and Boehringer, Sees Light-of-Day
Jardiance, which was approved in Europe in May of this year, was late in coming because of certain issues raised by the FDA at Boerhringer's manufacturing plant.
WHO Says Outbreak of Ebola Virus is Outpacing Control Efforts
In an ominous warning as fatalities mounted in West Africa from the worst known outbreak of the Ebola virus, the head of the World Health Organization said on Friday that the disease was moving faster than efforts to curb it, with potentially catastrophic consequences including a “high risk” that it will spread.
Bill Would Keep Medicaid Raise for Primary Care Through 2016
On July 30, 2 senators introduced a bill that would extend a Medicaid raise for primary-care physicians another 2 years through 2016 and make more clinicians eligible for the extra money.
HHS Final Rule Sets ICD-10 Switch for Oct. 1, 2015
In a final rule (PDF) issued Thursday afternoon, HHS formally set an Oct. 1, 2015, compliance date for conversion to ICD-10 diagnostic and procedure codes, incorporating the absolute minimum delay imposed by Congress when it ordered HHS to roll back the conversion date previously set for Oct. 1, 2014. Has Already Cost $840 Million, the federal health-exchange website plagued with glitches at its launch, has already cost $840 million to build, according to a Government Accountability Office (GAO) review of two task orders and one contract related to building the system.
Big Steps by the FDA to Improve Standards of Diagnostic Tests
Today, the U.S. Food and Drug Administration took important steps to ensure that certain tests used by health care professionals to help diagnose and treat patients provide accurate, consistent and reliable results.
House Authorizes Obamacare Lawsuit
The House passed a resolution Wednesday authorizing a lawsuit challenging President Barack Obama's constitutional authority to delay the employer mandate in the federal healthcare reform law. The measure was adopted on a 225-201 largely party-line vote.